` ATAI (ATAI Life Sciences NV) vs S&P 500 Comparison - Alpha Spread

ATAI
vs
S&P 500

Over the past 12 months, ATAI has significantly outperformed S&P 500, delivering a return of 62% compared to the S&P 500's 12% growth.

Stocks Performance
ATAI vs S&P 500

Loading
ATAI
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
ATAI vs S&P 500

Loading
ATAI
S&P 500
Difference
www.alphaspread.com

Performance By Year
ATAI vs S&P 500

Loading
ATAI
S&P 500
Add Stock

Competitors Performance
ATAI Life Sciences NV vs Peers

S&P 500
ATAI
LLY
JNJ
NOVO B
ROG
Add Stock

ATAI Life Sciences NV
Glance View

Market Cap
497.4m USD
Industry
Pharmaceuticals

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company engages in the treatment of mental health disorders. The company is headquartered in Berlin, Berlin and currently employs 81 full-time employees. The company went IPO on 2021-06-18. The firm is aiming to transform the treatment of mental health disorders.

ATAI Intrinsic Value
3.63 USD
Undervaluation 31%
Intrinsic Value
Price
Back to Top